After our second year of collaboration, the IMPACTIVE project partners have celebrated their second general assembly in Cagliari, hosted by the Italian partner CSGI. The discussions focused on setting our priorities for the next two years, as well as sharing the progress we have made over the past year.
Our project leader, the University of Montpellier, wears many hats. They ensure smooth collaboration among partners while leading the development of innovative mechanochemical methods at lab scale.
The IMPACTIVE team has investigated the manufacturing of the popular drug paracetamol using mechanochemistry. For the first time we accomplished the use of bead-milling technology for the solvent-free synthesis of the medicine, outperforming traditional solution-based methods.
On 13 and 14 June, IMPACTIVE will attend the EuroScience Open Forum 2024, held in Poland, with an exciting session about green pharma.
An API is the essential component responsible for the therapeutic effect of a medicine. This crucial element can be sourced from various methods. In this article we explore what APIs are, why are they important, and the strict regulations they face to ensure their quality and safety in pharmaceutical production worldwide.
The IMPACTIVE team has looked into the manufacturing of imatinib: an anticancer drug on the Essential Medicines’ list of the Worlds’ Health Organisation. Thanks to mechanochemistry, we discovered a synthetic route to do it in a way that is safer, greener and more efficient than the commercial method used nowadays.
Mechanochemistry is a groundbreaking field, revolutionizing chemistry through force-triggered reactions, eco-friendly practices, and efficient processes. It’s a pioneer technology with applications across multiple fields: biomass transformation, energy storage, agrochemicals, and much more. With its versatility and sustainability, it’s reshaping a myriad of industries towards a greener, more innovative future. Keep reading to unveil different use-cases.
IMPACTIVE is a very ambitious project, with members of the greatest background diversity. Altogether, we want to get rid of the solvents in the current pharmaceutical processes and substitute them with mechanochemistry, a greener, more sustainable approach.
After twelve months of collaboration, the IMPACTIVE project partners have celebrated a meeting in Lisbon, hosted by Portuguese partner IST-ID. The discussions delved into the developments of new mechanochemical methods, as well as useful strategies towards the protection of intellectual property towards commercialisation.
Have you ever thought about the environmental impact of the pills we take? We have, and we want to do something about it. From the different techniques we use, to the environmental analyses we perform, this article unravels all you need to know about IMPACTIVE.